UMass Medical School researchers to evaluate treatment options for early COVID-19 infection
UMass Healthcare College is taking part in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies
UMass Healthcare College is taking part in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies